Health IT companies' high stock prices may be at risk if attempts to lower the U.S. budget deficit involve cuts to meaningful use incentive payments, according to a Reuters report.
"These companies trade at multiples above their growth rate. [The stocks] have very little room for disappointment and have to consistently exceed expectations on every metric," said Maxim Group analyst Anthony Vendetti in the report.
Click here to read the full story in Becker's Hospital Review on health IT companies.
Click here to read the full story in Becker's Hospital Review on health IT companies.